Azelnidipine and Amlodipine: a Comparison of Their Pharmacokinetics and Effects on Ambulatory Blood Pressure.
Open Access
- 1 January 2003
- journal article
- clinical trial
- Published by Japanese Society of Hypertension in Hypertension Research
- Vol. 26 (3) , 201-208
- https://doi.org/10.1291/hypres.26.201
Abstract
We objected: 1) To compare the effects of azelnidipine and amlodipine on 24-h blood pressure; 2) To monitor the plasma concentration vs. the time profile in order to assess the association between pharmacokinetics and hypotensive activity after administration of either drug for 6 weeks. Blood pressure and pulse rate were measured by 24-h monitoring with a portable automatic monitor in a randomized double-blind study of 46 patients with essential hypertension. Azelnidipine 16 mg (23 patients) or amlodipine 5 mg (23 patients) was administered once daily for 6 weeks. Pharmacokinetics were analyzed after the last dose was taken. Both drugs showed similar effects on the office blood pressure and pulse rate. During 24-h monitoring, both drugs caused a decrease in systolic blood pressure of 13 mmHg and had a similar hypotensive profile during the daytime period (07:00-21:30). The pulse rate decreased by 2 beats/min in the azelnidipine group, whereas it significantly increased by 4 beats/min in the amlodipine group. Similar trends in the blood pressure and pulse rate were observed during the nighttime (22:00-6:30) and over 24 h. Excessive blood pressure reduction during the nighttime was not seen in either group. The pharmacokinetic results indicated that the plasma half-life (t1/2) of amlodipine was 38.5±19.8 h and that of azelnidipine was 8.68±1.33 h. Despite this difference in pharmacokinetics, the hypotensive effects of amlodipine and azelnidipine were similar throughout the 24-h administration period. (Hypertens Res 2003; 26: 201-208)Keywords
This publication has 27 references indexed in Scilit:
- Questionnaire survey on the Japanese guidelines for treatment of hypertension in the elderly: 1999 revised version.Hypertension Research, 2002
- Guidelines for the Management of Hypertension for General Practitioners.Hypertension Research, 2001
- Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertensionJournal Of Hypertension, 1998
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patientsThe Lancet, 1997
- Shanghai trial of nifedipine in the elderlyJournal Of Hypertension, 1996
- NifedipineCirculation, 1995
- The risk of myocardial infarction associated with antihypertensive drug therapiesPublished by American Medical Association (AMA) ,1995
- Pharmacologic profile of amlodipineThe American Journal of Cardiology, 1989
- Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.The Japanese Journal of Pharmacology, 1989